Health agencies will share cancer drug data

Health agencies will share cancer drug data

The Food and Drug Administration and the National Cancer Institute are teaming to up to build a grid-computing system that will let drug researchers share developmental data about cancer drugs.

The initiative will let researchers electronically submit applications to investigate new drugs, FDA commissioner Mark McClellan said. It also will give cancer researchers online access to FDA’s drug review databases, letting them access and evaluate clinical trial data, he said.

The effort is part of the cancer institute’s broader online initiative, the Cancer Biomedical Informatics Grid Project.

McClellan described the data-sharing project yesterday at a meeting of the President’s Information Technology Advisory Committee in Arlington, Va.

The project sprang from an interagency task force formed in May to study ways to expedite the review process for new cancer drugs.

For more information about the grid project, click on caBIG site.

About the Author

Connect with the GCN staff on Twitter @GCNtech.

Featured

  • FCW Perspectives
    remote workers (elenabsl/Shutterstock.com)

    Post-pandemic IT leadership

    The rush to maximum telework did more than showcase the importance of IT -- it also forced them to rethink their own operations.

  • Management
    shutterstock image By enzozo; photo ID: 319763930

    Where does the TMF Board go from here?

    With a $1 billion cash infusion, relaxed repayment guidelines and a surge in proposals from federal agencies, questions have been raised about whether the board overseeing the Technology Modernization Fund has been scaled to cope with its newfound popularity.

Stay Connected